Delivery Order SPE2DB24D9228-SPE2DB25FATFU
Award Date
3/6/25
Potential Completion Date
3/27/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The firm fixed-price delivery order, valued at $7,146.90, has an ultimate completion date of September 19, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications, including branded and generic...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $5,002.83 for the procurement of NEXPLANON 68 MG IMPLANTS. The contract is a firm fixed-price award with no set-aside designation, issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. DMS Pharmaceutical Group specializes in supplying a wide range of pharmaceutical products and medical supplies to the Department of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of NEXPLANON 68 MG IMPLANTS. The contract, valued at $33,326.88, has an ultimate completion date of February 12, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The $7,146.90 firm fixed-price delivery order has an ultimate completion date of September 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The award has a ceiling value of $7,146.90 and is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of NEXPLANON 68 MG IMPLANTS. The contract, valued at $16,663.44, has an ultimate completion date of March 25, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The contract has a potential value of $3,573.45 and a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles (IDVs) with DLA to supply a variety of pharmaceuticals and medical products to military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed-price delivery order worth $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NEXPLANON 68 MG IMPLANTS. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued up to $4,999,999 through 2025, which enables the agency to order a broad range of pharmaceutical products to support military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. The contract, valued at $8,576.28, has an ultimate completion date of July 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, that allows the DLA to issue firm fixed-price delivery orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Firm Fixed Price delivery order worth $4,288.14 awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a performance period through October 21, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical...